.png){kind=icon}
返回
Chemoimmunotherapy combinations: translating basic knowledge into clinical successes
.png){kind=icon}
OA
AI
DOI：10.1038/s41435-024-00264-9.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
While chemotherapeutic agents were long solely associated with immunosuppression, clinical data demonstrate that the combination of some chemotherapies with immunomodulators can be beneficial against cancer. Defining combinations featuring optimal anticancer activity along with minimal toxicity remains however a major challenge. Clinical evidence suggests that immune responses in patients treated with combination therapies are associated with progression-free survival. Progress in understanding the mechanisms responsible for anticancer immune responses following chemotherapy administration facilitated the translation of relevant chemoimmunotherapy combinations in the clinic.
Keyword:
CHEMOTHERAPY
BLOCKADE
CANCER
IMMUNOTHERAPY
DAUNORUBICIN
期刊
IF:
4.5
论文数:
1.8K
被引数:
2.6K
机构
引用论文
The blockade of immune checkpoints in cancer immunotherapy癌症免疫疗法中免疫检查点的阻断.png)
NATURE REVIEWS CANCER
OAAI
NATURE REVIEWS CANCERIF66.8
OAAI分享收藏Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 studyLANCET
LANCETIF88.5
PREAI
分享收藏Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint InhibitorsCELLSOAAI
CELLSIF5.2
OAAI分享收藏Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?免疫原性化疗能否缓解癌细胞对免疫检查点抑制剂的耐药性？OAAI
OAAI分享收藏First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial一线durvalumab和tremelimumab联合化疗治疗RAS突变的转移性结直肠癌: 1b/2期试验NATURE MEDICINEOAAI
NATURE MEDICINEIF50
OAAI分享收藏Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy免疫原性化疗使肿瘤对检查点阻断疗法敏感IMMUNITYOAAI
IMMUNITYIF26.3
OAAI分享收藏Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors免疫检查点抑制剂时代的化疗免疫刺激
PREAI
分享收藏
查看更多内容